Capital Investment Counsel (Colorado)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.27M Buy
20,071
+369
+2% +$126K 0.9% 46
2026
Q1
$6.93M Buy
19,702
+644
+3% +$230K 0.95% 41
2025
Q4
$6.24M Buy
19,058
+695
+4% +$220K 0.87% 50
2025
Q3
$5.18M Buy
18,363
+375
+2% +$109K 0.76% 57
2025
Q2
$5.02M Sell
17,988
-454
-2% -$129K 0.78% 59
2025
Q1
$5.75M Sell
18,442
-176
-0.9% -$52K 0.95% 48
2024
Q4
$4.85M Buy
18,618
+431
+2% +$128K 0.81% 57
2024
Q3
$5.86M Buy
18,187
+617
+4% +$202K 1.01% 50
2024
Q2
$5.49M Buy
17,570
+1,105
+7% +$325K 1.08% 42
2024
Q1
$4.68M Buy
16,465
+6,485
+65% +$1.9M 1% 46
2023
Q4
$2.87M Buy
+9,980
New +$2.72M 1.08% 46

Other funds holding AMGN

Capital Investment Counsel (Colorado)'s AMGN Position: Q2 2026 in Review

Capital Investment Counsel (Colorado) increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $126K and bringing the position to 20,071 shares worth $7.27M. The position accounts for 0.9% of the portfolio, ranked #46.

Capital Investment Counsel (Colorado) first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,709 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Investment Counsel (Colorado) held 20,071 shares of Amgen worth $7.27M as of Q2 2026.
  • Capital Investment Counsel (Colorado) bought 369 Amgen shares in Q2 2026, an estimated $126K.
  • Amgen made up 0.9% of Capital Investment Counsel (Colorado)'s portfolio in Q2 2026, its #46 holding.
  • Capital Investment Counsel (Colorado) first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,709 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Investment Counsel (Colorado)'s 13F filing for Q2 2026, filed 15 Jul 2026.